Mantis, Nicholas J.
- Nysdoh/Health Research, Inc. (no department on record)
- Wadsworth Center (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #2,247
- Rising Star
- Program Leader
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2009 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$2.7M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#2,247
By linked amount among FY2023 PIs
Earliest Year Loaded
2009
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Mantis, Nicholas J. as a PI. Multi-PI records show the full award amount for context.
- 75N93019C00040-P00018-9999-1N01Contact PILyme Disease: B cell epitope discovery and mechanisms of antibody protection$1.9Maward amount
- 3U01CA260508-02S1U01Contact PIHigh-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology$824.6Kaward amount
Award organizations
Organizations that administered FY2023 awards listing Mantis, Nicholas J. as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2009First NIH AwardNysdoh/Health Research, Inc.
- 2010Multi-Institutional ResearchAwards at 2 institutions
- 2015$500K Cumulative Funding
- 2016$1M Cumulative Funding
- 2016Entered Top 50% NationallyRanked #5174
- 2017$2M Cumulative Funding
- 2017Entered Top 25% NationallyRanked #5000
- 2017Program/Center Grant Leader
- 2019$5M Cumulative Funding
- 2022$10M Cumulative Funding
- 2022Entered Top 10% NationallyRanked #1283